CORT icon

Corcept Therapeutics
CORT

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$80
73% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Swayampakula Ramakanth
44% 1-yr CORT win rate
25 Feb ‘26 1 month ago
Canaccord Genuity
Canaccord Genuity
Edward Nash
50% 1-yr CORT win rate
23 Jan ‘26 2 months ago